"DNA, Complementary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. cDNA (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe.
| Descriptor ID |
D018076
|
| MeSH Number(s) |
D13.444.308.497.220 D13.444.600.223.500 D27.720.470.530.600.223.260
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "DNA, Complementary".
Below are MeSH descriptors whose meaning is more specific than "DNA, Complementary".
This graph shows the total number of publications written about "DNA, Complementary" by people in this website by year, and whether "DNA, Complementary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 7 | 36 | 43 |
| 1995 | 3 | 32 | 35 |
| 1996 | 3 | 47 | 50 |
| 1997 | 5 | 40 | 45 |
| 1998 | 4 | 42 | 46 |
| 1999 | 6 | 57 | 63 |
| 2000 | 4 | 50 | 54 |
| 2001 | 2 | 56 | 58 |
| 2002 | 2 | 47 | 49 |
| 2003 | 4 | 61 | 65 |
| 2004 | 6 | 57 | 63 |
| 2005 | 4 | 41 | 45 |
| 2006 | 1 | 22 | 23 |
| 2007 | 0 | 24 | 24 |
| 2008 | 0 | 12 | 12 |
| 2009 | 1 | 6 | 7 |
| 2010 | 0 | 8 | 8 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 4 | 4 |
| 2013 | 1 | 6 | 7 |
| 2014 | 0 | 6 | 6 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 2 | 2 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 3 | 3 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA, Complementary" by people in Profiles.
-
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Clin Cancer Res. 2024 Mar 15; 30(6):1152-1159.
-
De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement. Am J Hum Genet. 2022 10 06; 109(10):1932-1943.
-
The recurrent de novo c.2011C>T missense variant in MTSS2 causes syndromic intellectual disability. Am J Hum Genet. 2022 10 06; 109(10):1923-1931.
-
Loss-of-function variants in TIAM1 are associated with developmental delay, intellectual disability, and seizures. Am J Hum Genet. 2022 04 07; 109(4):571-586.
-
Cloning and over Expression Studies of Ovine Somatotropin cDNA of Kajli (sheep breed) in a Prokaryotic System. J Oleo Sci. 2021 Dec 03; 70(12):1791-1796.
-
Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals. PLoS One. 2021; 16(8):e0244468.
-
Single-Cell Capture, RNA-seq, and Transcriptome Analysis from the Neural Retina. Methods Mol Biol. 2020; 2092:159-186.
-
Single-Cell RNA-Seq by Multiple Annealing and Tailing-Based Quantitative Single-Cell RNA-Seq (MATQ-Seq). Methods Mol Biol. 2019; 1979:57-71.
-
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer. Nat Commun. 2018 08 06; 9(1):3114.
-
Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma. Ann Clin Lab Sci. 2017 Sep; 47(5):523-528.